TCW Group’s Endologix Inc ELGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-2,144
Closed -$274K 721
2016
Q3
$274K Sell
2,144
-799
-27% -$102K ﹤0.01% 648
2016
Q2
$367K Sell
2,943
-27
-0.9% -$3.1K ﹤0.01% 645
2016
Q1
$248K Sell
2,970
-314
-10% -$25.9K ﹤0.01% 671
2015
Q4
$325K Buy
3,284
+201
+7% +$21.5K ﹤0.01% 662
2015
Q3
$378K Sell
3,083
-36,834
-92% -$5M ﹤0.01% 668
2015
Q2
$6.12M Sell
39,917
-8,773
-18% -$1.45M 0.04% 209
2015
Q1
$8.31M Sell
48,690
-44,603
-48% -$6.76M 0.04% 289
2014
Q4
$14.3M Buy
93,293
+3,383
+4% +$422K 0.06% 209
2014
Q3
$9.53M Sell
89,910
-1,647
-2% -$229K 0.04% 332
2014
Q2
$13.9M Buy
91,557
+1,582
+2% +$211K 0.06% 268
2014
Q1
$11.6M Buy
89,975
+4,221
+5% +$656K 0.05% 303
2013
Q4
$15M Sell
85,754
-14,183
-14% -$2.44M 0.06% 250
2013
Q3
$16.1M Sell
99,937
-37,219
-27% -$5.86M 0.07% 219
2013
Q2
$18.2M Buy
+137,156
New +$19.4M 0.09% 188

Other funds holding ELGX

TCW Group's ELGX Position: Q4 2016 in Review

TCW Group sold out of Endologix Inc (ELGX) in Q4 2016, closing a stake of 2,144 shares — an estimated $274K sold.

TCW Group first reported a position in ELGX in Q2 2013 and held it in 14 quarters. The position peaked at $18.2M in Q2 2013. 140 funds tracked by Wall St. Rank hold ELGX as of Q4 2016.

  • TCW Group reported no remaining Endologix Inc position as of Q4 2016 after selling out during the quarter.
  • TCW Group sold 2,144 Endologix Inc shares in Q4 2016, an estimated $274K.
  • TCW Group first reported a position in Endologix Inc in Q2 2013 and held it in 14 quarters.
  • TCW Group's Endologix Inc position peaked at $18.2M in Q2 2013.
  • 140 funds tracked by Wall St. Rank held Endologix Inc as of Q4 2016.

Based on TCW Group's 13F filing for Q4 2016, filed 10 Feb 2017.